Epidemic Keratoconjunctivitis (EKC)

Epidemic keratoconjunctivitis is a very contagious eye infection that affects both the conjunctiva (the thin clear layer covering the white part of the eye and the inside of the eyelids) and the cornea (the front, transparent part of the eye). It is caused almost always by certain types of adenoviruses, which are common viruses that can infect the eyes, respiratory system, and other parts of the body. EKC is called “epidemic” because it tends to occur in clusters—many people get it quickly in places like clinics, schools, or nursing homes. It can spread easily from person to person or through things that have touched an infected eye. EKC is known for causing not just red eyes and discharge, but also deeper involvement of the cornea, leading to symptoms like blurred vision that may linger even after the initial infection seems to get better. This makes it more severe than simple viral conjunctivitis. PMC ScienceDirect Merck Manuals

Epidemic Keratoconjunctivitis is a highly contagious eye infection caused by certain types of adenoviruses, most commonly types 8, 19, and 37. It involves both the conjunctiva (the thin membrane lining the eyelids and covering the white of the eye) and the cornea (the clear front surface of the eye), leading to inflammation, redness, tearing, discomfort, and sometimes blurred vision. EKC tends to occur in clusters or outbreaks—hence “epidemic”—especially in settings like clinics, schools, and nursing homes where close contact or shared instruments facilitate spread. The disease usually begins with a prodromal phase resembling a mild cold or flu, followed by acute eye redness, tearing, foreign-body sensation, and in many cases, development of subepithelial infiltrates in the cornea that can cause visual blurring; these may persist weeks to months. There is no definitive antiviral “cure,” so management centers on symptom relief, limiting spread, and controlling inflammation when necessary. PMCPMCNCBIVerywell Health

---

Types / Variants of EKC

EKC is not divided into formally separate “diseases” the way some illnesses are, but it does have variants based on the adenovirus serotype causing the infection, the severity of corneal involvement, and whether pseudomembranes (false membranes on the conjunctiva) form.

• By serotype: The most common adenovirus serotypes that cause EKC are Type 8, 19, and 37, although other types such as 2, 3, 4, 5, 7, 10, 11, 21, 22, 29, and 34 have also been implicated in outbreaks or milder variants. Some serotypes lead to more widespread epidemics and more intense corneal inflammation. PMCwww.elsevier.com

• With or without pseudomembranes: Some patients develop pseudomembranes—sticky white-gray sheets on the inner eyelid or conjunctiva that can peel off and sometimes cause bleeding when removed. Their presence usually means a more intense immune response and a longer recovery. WebEye

• Corneal involvement spectrum: EKC ranges from cases with mild superficial punctate keratitis (tiny tiny dots of damage on the corneal surface) to deeper subepithelial infiltrates (immune deposits under the cornea surface) that can persist for weeks or months, causing blurred vision and glare. Some rare severe cases develop large geographic epithelial defects. Clinical Insights in EyecareWebEye

---

Causes / Risk and Exposure Factors for EKC

EKC isn’t caused by twenty different pathogens—it’s caused by adenovirus—but there are twenty common ways or risk situations in which the virus is introduced to the eye or spreads, making a person more likely to get EKC:

1. Direct contact with an infected person’s eye secretions, such as touching their eye and then your own. PMC

2. Touching contaminated surfaces or objects (fomites) like doorknobs, light switches, or shared devices that have virus from an infected eye. Lippincott Journals

3. Using contaminated ophthalmic instruments (e.g., slit lamp chin rests, tonometer tips, or eye drop dispensers) without proper disinfection. JSTOR

4. Sharing towels, face cloths, or makeup with someone who has EKC. Lippincott Journals

5. Contaminated multi-dose eye drops, especially if the tip touches an infected eye or eyelid and is reused. ResearchGate

6. Close contact in crowded or institutional settings such as schools, nursing homes, or hospital eye clinics, where the infection easily passes between people. AAO

7. Inadequate hand hygiene among patients or health care workers, leading to transfer of virus from surfaces to the eye. JSTOR

8. Unclean contact lens handling or storage, introducing adenovirus to the eye from contaminated hands or lens cases. Lippincott Journals

9. Swimming in inadequately chlorinated pool water, which can carry adenoviruses and infect the eye. PMC

10. Exposure to respiratory droplets from a person shedding adenovirus (since adenoviruses can also spread via respiratory secretions). Lippincott Journals

11. Touching your own eyes after touching your nose or mouth, where adenovirus may be present from a concurrent or recent upper respiratory infection. Merck Manuals

12. Ophthalmic surgical procedures or examinations where sterilization was incomplete, allowing virus transfer. JSTOR

13. Healthcare-related outbreaks due to lapses in infection control in eye clinics. ResearchGate

14. Household spread when one family member has EKC and shares common living items. PMC

15. Close physical proximity to someone in the early phase of EKC (prodromal phase), when they might have mild systemic symptoms but already be contagious. PMC

16. Travel or visiting regions during active outbreaks, increasing chance of encountering contaminated settings. AAO

17. Immunological factors—while EKC can infect healthy people, immune system variation may alter severity or persistence (e.g., mild immune suppression may allow longer shedding and transmission). PMC

18. Failure to isolate infected individuals in clinics or schools, allowing continued spread. AAO

19. Environmental persistence of adenovirus on surfaces, since the virus can survive for days and infect someone who later touches the surface. Lippincott Journals

20. Genetic variation in adenovirus (new genome types) leading to more efficient spread or severity, as seen with different genome types of serotype 37 in documented outbreaks. PMC

---

Symptoms of EKC

EKC typically affects both eyes (often starting in one and spreading to the other) and brings a mix of local eye symptoms plus some mild systemic signs in some people. The common symptoms are:

1. Redness of the eye – due to inflammation of the conjunctiva and sometimes deeper layers. WebEyeMerck Manuals

2. Tearing (watery discharge) – constant tearing is typical and differs from thick pus of bacterial infections. WebEye

3. Foreign body sensation – feeling like something is in the eye; caused by irritation of the cornea and conjunctiva. NCBI

4. Photophobia (light sensitivity) – the eye becomes more sensitive to light because of corneal involvement. Merck Manuals

5. Blurred vision – often from corneal subepithelial infiltrates or punctate keratitis affecting the smoothness of the optical surface. WebEyeClinical Insights in Eyecare

6. Discharge that is watery or mucoid – lighter than purulent; may crust eyelids in the morning. WebEye

7. Eyelid swelling or puffiness – mild edema with inflammation, especially in early phases. WebEye

8. Preauricular lymph node swelling (lymphadenopathy) – a key sign that helps distinguish EKC from allergic causes. EyeWikiWebEye

9. Conjunctival follicles – small bumps under the eyelid indicating viral immune reaction. NCBI

10. Pseudomembrane formation – sticky sheets on the conjunctiva that may bleed if removed. WebEye

11. Subepithelial infiltrates – seen later, these are immune deposits under the corneal surface that cause persistent visual blurring. PMCWebEye

12. Superficial punctate keratitis – tiny damage spots on the corneal surface detectable with dye staining. Merck ManualsNCBI

13. Eyelid crusting on waking – due to discharge drying, making the lashes stick together. WebEye

14. Mild systemic symptoms such as low-grade fever, headache, or fatigue in some cases, especially early in the illness. EyeWiki

15. Stringy mucus or membrane-like discharge – sometimes more tenacious than simple tearing, reflecting the inflammatory response. WebEye

---

Diagnostic Tests for EKC

EKC is most often diagnosed by clinical examination, but when confirmation, severity assessment, epidemiology, or ruling out other causes is needed, the following tests are used. Each is explained below in simple terms.

A. Physical Exam

1. Visual Acuity Measurement
   This checks how clearly the patient sees. EKC involving the cornea (like subepithelial infiltrates) can blur vision; tracking changes helps assess the impact on vision. NCBI

2. External Eye Inspection
   Looking at the outside of the eye for redness, eyelid swelling, discharge, and conjunctival injection. This gives an initial clue that inflammation is present. NCBI

3. Slit-Lamp Examination
   A close, magnified look at the conjunctiva, cornea, and tear film using a microscope with a focused light. This allows the doctor to see follicles, pseudomembranes, punctate defects, and subepithelial infiltrates. It is essential for differentiating EKC from other eye problems. NCBINCBI

4. Fluorescein Staining
   A special dye is placed in the eye to highlight surface damage on the cornea. Under a blue light, tiny areas of injury (punctate keratitis) or larger epithelial defects show up clearly. Merck Manuals

5. Palpation of Preauricular Lymph Nodes
   Feeling the lymph node in front of the ear to see if it is swollen. This swelling is common in EKC and supports a viral cause over allergic or some bacterial conjunctivitis. EyeWikiWebEye

6. Assessment of Pseudomembranes via Eyelid Eversion
   The doctor gently flips the eyelid to look for sticky membrane-like layers on the conjunctiva. Finding pseudomembranes suggests a stronger inflammatory response. WebEye

7. Assessment of Photophobia and Comfort
   Asking the patient about sensitivity to light and discomfort gives functional data on how much the cornea is affected, guiding further testing. Merck Manuals

B. Manual (Bedside / Simple) Tests

8. Eyelid Eversion (Detailed Manual Inspection)
   Simply flipping the eyelid to inspect for follicles, membranes, or debris—it is a hands-on manual check supplementing slit-lamp findings. WebEye

9. Tear Break-Up Time (TBUT)
   Measures how quickly the tear film breaks on the surface of the eye. EKC may disturb the tear layer indirectly; changes help evaluate surface instability and secondary irritation. NCBI

10. Corneal Sensitivity Testing (Esthesiometry)
    Although not routine for every patient, a small manual instrument (like a Cochet-Bonnet esthesiometer) tests how sensitive the cornea is. Viral inflammation can alter corneal nerve function and sensitivity. NCBIPMC

C. Lab and Pathological Tests

11. Polymerase Chain Reaction (PCR) for Adenovirus from Conjunctival Swab
    This is a molecular test that looks for adenovirus DNA and is very sensitive and specific. It can confirm the virus and is useful in outbreak tracking. PMCResearchGate

12. Rapid Antigen Detection Test
    These are point-of-care tests that detect viral proteins (antigens) from eye discharge. They work best in the first week when viral load is high. They give faster results than PCR. Review of Optometry

13. Viral Culture
    Growing the virus from a sample in a lab. It takes longer but historically was used to confirm adenovirus and study outbreaks; less commonly used now due to the speed of PCR. PMC

14. Direct Immunofluorescence Assay
    Uses labeled antibodies to visually tag adenoviral antigens in conjunctival cells under a special microscope. It helps identify the virus directly on scrapings. PMC

15. Adenovirus Typing / Genotyping
    After detecting adenovirus, further lab work can identify the specific serotype or genome type. This is important during epidemics to understand spread patterns and link cases. PMCBioMed Central

16. Conjunctival Cytology (Cell Examination)
    Looking at cells from the conjunctiva under a microscope can help rule out other causes and see the pattern of inflammation (e.g., viral-type follicular response). NCBI

D. Electrodiagnostic / Functional Tests

17. Corneal Esthesiometry (as a Functional Nerve Test)
    Measures nerve function on the surface of the cornea. Inflammation from EKC can change sensitivity; this is more often used in research or prolonged cases to assess healing. NCBIPMC

18. Ocular Surface Sensitivity Mapping
    A more detailed version of sensitivity testing, sometimes used to track recovery of corneal nerves after deep immune reactions (such as subepithelial infiltrates in EKC). This helps understand chronic discomfort or visual blurring beyond obvious inflammation. PMC

E. Imaging / Advanced Visualization Tests

19. In Vivo Confocal Microscopy
    A high-resolution imaging tool that lets doctors see cells in the cornea and conjunctiva in real time. It can show subepithelial infiltrates and the state of corneal immune cells, helping to document and sometimes distinguish stages of EKC. Clinical Insights in EyecareScienceDirect

20. Anterior Segment Optical Coherence Tomography (AS-OCT)
    A non-contact imaging technique that produces cross-sectional images of the cornea layers. It helps visualize the depth and location of infiltrates or epithelial defects to quantify severity and monitor healing. Clinical Insights in EyecareScienceDirect

Non-Pharmacological Treatments

1. Cold Compresses
   Applying a cool, clean compress to the affected eye reduces swelling, discomfort, and the burning sensation. The cold constricts superficial blood vessels, decreasing redness and provides soothing relief. Use a soft cloth soaked in cool water for 10–15 minutes several times daily, ensuring the cloth is fresh to avoid spreading infection. MDPITaylor & Francis Online

2. Preservative-Free Artificial Tears
   Lubricating the ocular surface with preservative-free artificial tears helps dilute viral particles, soothes irritation, and maintains tear film stability. Frequent instillation (every 2–4 hours or as needed) reduces foreign-body sensation and helps wash away debris. They have virtually no adverse effects and are first-line for symptom relief. NCBITaylor & Francis Online

3. Avoiding Eye Rubbing
   Eye rubbing spreads adenovirus from one eye to the other or to surfaces. It can also exacerbate inflammation and risk secondary problems. Patients are counseled to resist touching their eyes and to use clean tissues if wiping is necessary. PMC

4. Strict Hand Hygiene
   Frequent hand washing with soap and water or use of alcohol-based hand rubs (when hands are not visibly soiled) removes viral particles picked up from the eyes or contaminated surfaces. Cleaning hands before and after touching the face or eyes breaks transmission chains. CDCPMChartmann-science-center.com

5. Patient Education and Isolation
   Informing affected individuals about contagiousness, the importance of not sharing towels or eye drops, and avoiding close contact (especially in workplaces, schools, and clinics) slows outbreaks. Isolation for the acute phase, especially if in communal settings, reduces spread. CDCCDC

6. Dedicated Single-Patient Eye Drop Vials and Devices
   Reusing multi-dose vials across patients risks cross-contamination. Dedicating eye drop bottles, pads, and instruments to a single patient during an outbreak prevents iatrogenic spread. CDC

7. Surface and Instrument Disinfection
   Adenoviruses can survive on inanimate surfaces for days. Using EPA-registered disinfectants known to kill adenoviruses, compatible with the surface, and following contact time instructions is essential in clinics and homes. Instruments must be properly soaked or wiped between patients. CDCAAOAAO

8. Avoiding Contact Lens Wear
   Contact lenses can trap virus and prolong inflammation or cause mechanical irritation; they also increase risk of secondary infection. Wear should be stopped during active infection; lenses and cases should be discarded or thoroughly disinfected before resuming. PMC

9. Environmental Control (Avoid Shared Towels/Pillows)
   Fomites like towels, washcloths, eye make-up, or pillowcases can carry adenovirus. Using separate linens and laundering them in hot water with detergent limits transmission. college-optometrists.org

10. Proper Disposal of Tissues and Single-Use Items
    Used tissues, cotton swabs, or wipes should be discarded immediately in closed bins to prevent contamination of surfaces or hands of others. PMC

11. Eye Lid Hygiene
    Gently cleaning the eyelid margins with sterile saline or diluted baby shampoo (if crusting is present) helps keep the ocular surface clean and reduces debris that can exacerbate inflammation. Taylor & Francis Online

12. Reducing Environmental Irritants
    Avoiding cigarette smoke, dust, and strong winds prevents further irritation of already inflamed conjunctiva and cornea. A calm, clean indoor environment promotes comfort and healing. NCBI

13. Avoidance of Allergens (if overlap with allergic symptoms)
    If a person has preexisting ocular allergies, controlling airborne allergens (using air purifiers, keeping windows closed during high pollen) reduces additive inflammation. MDPI

14. Use of Sunglasses/UV Protection
    Bright light and UV irritation worsen symptoms like photophobia. Sunglasses with good coverage reduce discomfort and protect the cornea during the vulnerable healing phase. NCBI

15. Rest and Hydration
    General health support—adequate sleep and drinking enough fluids—helps the immune system respond effectively to viral infection. Dehydration can thicken secretions and worsen ocular surface dryness. MDPI

16. Avoiding Topical Irritants
    Avoid using non-prescribed drops, especially those containing preservatives or vasoconstrictors that can cause rebound redness or chemical irritation. NCBI

17. Tear Film Stabilization by Blink Exercises
    Conscious, full blinking helps distribute tears and support epithelial repair, especially if patients are over-focusing on screens which reduces blink rate. NCBI

18. Use of Humidified Air
    Dry air worsens ocular discomfort. Humidifiers keep ambient humidity at a comfortable level, preserving the tear film and reducing scratchiness. NCBI

19. Early Recognition and Prompt Minimal Intervention
    Educating patients to seek early care if symptoms worsen leads to timely identification of complications (e.g., subepithelial infiltrates) and prevents inappropriate self-treatment that might spread the virus. PMCPMC

20. Controlled Use of Eye Patching (Rare/Selective)
    In very select cases with severe discomfort, brief patching (with care to avoid hypoxia and only under clinician advice) may reduce photophobia; prolonged patching is avoided because it can delay healing or trap pathogens. NCBI

---

Drug Treatments

1. Topical Corticosteroids (e.g., Loteprednol 0.5%, Prednisolone Acetate 1%)
   Class: Anti-inflammatory. Purpose: To reduce immune-mediated corneal subepithelial infiltrates that cause persistent vision blurring and discomfort. Mechanism: Suppresses local inflammation by inhibiting cytokine production and immune cell migration. Dosage: Typically initiated as four times daily with a gradual taper over weeks based on response; loteprednol is often preferred for a safer profile. Caution: Must be used under ophthalmologist supervision because prolonged use can raise intraocular pressure or risk secondary infection. PMCPJMHS OnlineCochrane Library

2. Topical Tacrolimus (off-label for persistent infiltrates)
   Class: Calcineurin inhibitor (immunomodulator). Purpose: Used in cases where subepithelial infiltrates persist despite or to reduce steroid exposure; also can be combined with low-dose steroids. Mechanism: Inhibits T-cell activation and cytokine release, dampening chronic immune infiltration. Dosage: Commonly 0.03–0.1% ophthalmic formulation, applied twice daily; regimens vary based on severity. Evidence shows benefit both alone and with low-dose prednisolone for refractory cases. PMC

3. Topical Cyclosporine A (e.g., 0.05%)
   Class: Immunomodulator. Purpose: Alternative or adjunct to steroids for chronic inflammation and preventing recurrence of infiltrates. Mechanism: Suppresses T-cell mediated inflammation by inhibiting calcineurin pathway. Dosage: Usually twice daily; used longer term to reduce steroid dependence. Comparative studies have evaluated its role versus steroids in recurrence control. PJMHS Online

4. Topical Povidone-Iodine (PVP-I) with or without Low-Dose Steroid (e.g., 2.5% PVP-I + 0.1% Fluorometholone)
   Class: Antiseptic (PVP-I) with optional anti-inflammatory adjunct. Purpose: Early reduction of viral load on the ocular surface and modulating inflammation. Mechanism: PVP-I directly inactivates adenovirus on the surface; the steroid mitigates inflammatory response. Dosage: Protocols vary, but some studies used topical 2.5% PVP-I applied with mild anesthesia, followed by short courses of low-potency steroids. This combination has shown shortened symptom duration and severity. PMCResearchGateClinical Insights in Eyecare

5. Topical Broad-Spectrum Antibiotic Ointment (e.g., Erythromycin or Fluoroquinolone prophylactically)
   Class: Antibiotic (prophylaxis). Purpose: Prevent secondary bacterial infection, which can complicate the inflamed ocular surface. Mechanism: Provides a protective antibacterial layer while the underlying viral inflammation resolves. Dosage: Typically applied 3–4 times daily until acute discharge subsides; not for treating the viral infection itself. NCBI

6. Topical Antihistamine/Mast Cell Stabilizer Drops (e.g., Olopatadine)
   Class: Antihistamine/anti-allergic. Purpose: Alleviate itching and discomfort when there is overlapping allergic component or ocular surface irritation. Mechanism: Blocks histamine receptors and stabilizes mast cells, reducing itching and tearing. Dosage: As per product labeling, often once or twice daily. Note: Not directly antiviral, but can improve subjective comfort. MDPI

7. Oral Corticosteroids (Selected Severe or Pediatric Cases)
   Class: Systemic anti-inflammatory. Purpose: In situations where topical drops are impractical (e.g., very young children) or inflammation is widespread and severe, short-course oral steroids can be used as adjuncts. Mechanism: Systemic suppression of immune-mediated corneal inflammation. Dosage: Tailored individually—short courses at moderate dose under physician supervision. Evidence shows benefit in select severe EKC, especially when compliance with drops is poor. Lippincott Journals

8. Investigational Antivirals (e.g., Cidofovir – Experimental Use Only)
   Class: Antiviral nucleotide analogue. Purpose: Has been studied for direct antiviral activity against adenovirus but is not standard therapy due to toxicity concerns. Mechanism: Inhibits viral DNA polymerase, impairing viral replication. Dosage & Safety: Topical formulations in research settings; not routinely used because of risk of ocular surface toxicity and lack of approved indication. PMCWiley Online Library

9. Supportive Mucolytic/Surface Protectants (e.g., Hyaluronic Acid Drops)
   Class: Viscous lubricants. Purpose: Enhances tear film, promotes epithelial healing, and reduces friction. Mechanism: Binds water and forms a protective layer over ocular surface cells to keep them hydrated and aid recovery. Dosage: Several times daily or as needed. NCBI

10. Topical Interferon (e.g., Interferon Alpha-2b – Experimental/Adjunct in Viral Conjunctivitis)
    Class: Immunomodulatory antiviral cytokine. Purpose: Explored in some viral conjunctivitis contexts to boost local antiviral responses. Mechanism: Stimulates host antiviral gene expression, limiting viral replication. Dosage: Varied in studies; not yet standard for EKC, and evidence is limited—use only in clinical trial or specialist settings. MDPI

---

Dietary Molecular Supplements (Immune/Supportive; Not Cures)

Because no supplement cures EKC directly, the following support the immune system and ocular surface health. Doses are typical adult amounts; adjust for age, kidney/liver function, and medical conditions; check with a clinician before combining high doses.

1. Vitamin C (Ascorbic Acid)
   Function: Antioxidant that supports white blood cell function and mucosal immunity. Mechanism: Enhances neutrophil activity and limits oxidative damage. Dosage: 500 mg twice daily; avoid >2000 mg/day to reduce gastrointestinal upset. MDPI

2. Vitamin D3
   Function: Modulates innate and adaptive immunity, may reduce viral infection severity. Mechanism: Enhances antimicrobial peptide expression and regulates inflammation. Dosage: 1000–2000 IU daily (higher if deficient, based on blood level). MDPI

3. Zinc (Zinc Gluconate or Zinc Picolinate)
   Function: Essential for antiviral immunity and mucosal barrier integrity. Mechanism: Inhibits viral replication and supports T-cell function. Dosage: 15–25 mg elemental zinc daily; avoid chronic high-dose (>40 mg) without supervision. MDPI

4. Selenium
   Function: Antioxidant cofactor that supports immune competence. Mechanism: Reduces viral mutation and oxidative stress in immune cells. Dosage: 100 mcg daily; avoid exceeding 200 mcg/day due to toxicity. MDPI

5. Omega-3 Fatty Acids (EPA/DHA)
   Function: Anti-inflammatory support for mucosal surfaces. Mechanism: Resolvin formation dampens excessive inflammation without suppressing needed immune responses. Dosage: 1000 mg combined EPA/DHA daily from fish oil supplements or fatty fish. MDPI

6. Lactoferrin
   Function: Natural antimicrobial and immune-supportive protein found in tears and secretions. Mechanism: Binds iron (limiting pathogen growth), modulates immune responses, and has antiviral effects. Dosage: 100 mg oral supplement twice daily; formulations vary. MDPI

7. N-Acetylcysteine (NAC)
   Function: Precursor to glutathione, helps with oxidative stress and mucus thinning. Mechanism: Boosts cellular antioxidant capacity and improves mucosal clearance. Dosage: 600 mg twice daily. MDPI

8. Probiotics (e.g., Lactobacillus rhamnosus)
   Function: Support gut-immune axis, which indirectly influences systemic antiviral defense. Mechanism: Modulation of systemic cytokine milieu and enhancement of mucosal barrier immunity. Dosage: As per product (often 1–10 billion CFU daily). MDPI

9. Quercetin
   Function: Flavonoid with mild antiviral and anti-inflammatory properties. Mechanism: Inhibits viral entry and replication pathways, and stabilizes mast cells. Dosage: 250–500 mg twice daily with food. MDPI

10. Beta-Glucans (from yeast or oats)
    Function: Immune modulator that primes innate immunity. Mechanism: Activates macrophages and natural killer cells for quicker viral recognition. Dosage: Commonly 250–500 mg daily. MDPI

Note: These supplements should not replace the primary medical care for EKC; they are supportive and best used when baseline nutritional status is suboptimal or to help general immune responsiveness. Always discuss with a healthcare provider before combining with other medications. MDPI

---

“Hard Immunity / Regenerative / Stem Cell” Approaches

1. Topical Tacrolimus and Cyclosporine (Immunomodulators for Persistent Inflammation)
   These are not classic “stem cell” drugs but represent active modulation of the immune system to prevent chronic damage from immune-mediated infiltrates, allowing the ocular surface to recover more fully without prolonged steroid exposure. Their use promotes regenerative healing by reducing destructive inflammation. Dosages and use have been outlined above. PMCPJMHS Online

2. Amniotic Membrane Transplantation (Biologic Surface Regenerator)
   Procedure: Application (often sutured or glued) of processed human amniotic membrane to the ocular surface. Purpose: For severe epithelial defects or inflammation that is not healing, amniotic membrane provides a substrate rich in anti-inflammatory and regenerative cytokines, promoting surface repair. Mechanism: Releases growth factors, dampens fibrosis, and facilitates epithelial migration. While not a drug, it’s a regenerative biologic frequently used for complicated ocular surface healing. tjceo.com

3. Limbal Stem Cell Transplantation (for Secondary Surface Damage)
   In rare, severe or chronic cases where EKC-related inflammation leads to limbal stem cell deficiency (disruption of the corneal epithelial stem cell niche), transplanting healthy limbal stem cells restores the regenerative capacity of the corneal epithelium. This is advanced and used only for significant surface failure, not typical EKC. tjceo.com

4. Recombinant Human Nerve Growth Factor (Cenegermin) — Indirect Regenerative Support
   Used primarily for neurotrophic keratitis, this agent promotes corneal healing by revitalizing impaired innervation and epithelial repair. In complicated EKC where epithelial healing is severely delayed, such regenerative strategies may be considered off-label in specialist settings. NCBI

5. Topical Interferon (Immune Priming for Viral Clearance)
   As described earlier, interferons can enhance antiviral state in ocular surface cells, potentially aiding the immune system’s regenerative response by limiting continued viral insult. Their use remains experimental for EKC and is not yet standardized. MDPI

6. Systemic Immune Support in Immunocompromised Hosts
   In patients with impaired immunity (e.g., HIV, systemic immunosuppressants), optimizing systemic immune health—through medically supervised adjustment of immunosuppressive therapy or treatment of underlying deficiency—allows the body’s regenerative ocular defenses to function more effectively. This is general medical management rather than a single drug. MDPI

Note: There is currently no approved vaccine or standard “stem cell drug” specifically for EKC; most regenerative work addresses secondary damage or prolonged healing. PMCtjceo.com

---

Surgical or Procedural Interventions

1. Superficial Keratectomy / Epithelial Debridement
   Procedure: Gentle removal of abnormal corneal epithelium or localized subepithelial infiltrates. Why Done: To clear persistent infiltrates that degrade vision and to stimulate fresh epithelial healing. This can improve vision when infiltrates cause irregularities. tjceo.com

2. Phototherapeutic Keratectomy (PTK)
   Procedure: Excimer laser ablation of superficial corneal scars or irregularities. Why Done: EKC can lead to superficial scarring or irregular epithelium; PTK smooths the surface and improves clarity and vision. tjceo.com

3. Amniotic Membrane Placement (Surgical Biologic Graft)
   As noted earlier, for non-healing epithelial defects or severe surface inflammation, the amniotic membrane is applied surgically to promote healing. tjceo.com

4. Corneal Transplantation (Lamellar or Penetrating Keratoplasty)
   Procedure: Partial or full-thickness corneal replacement. Why Done: Reserved for deep, visually significant scarring that does not respond to conservative or less invasive interventions. This restores corneal transparency when scarring has caused irreversible opacity. tjceo.com

5. Tarsorrhaphy (Temporary Eyelid Closure)
   Procedure: Partial sewing together of eyelids. Why Done: In severe cases with exposure-related epithelial breakdown or poor healing, temporarily narrowing the palpebral fissure protects the ocular surface to allow regenerative healing. NCBI

---

Prevention Strategies

1. Frequent and Proper Hand Washing
   Use soap and water for at least 20 seconds, drying with a clean towel; scrubbing removes virus from hands before touching the face or eyes. CDC

2. Disinfection of Surfaces with Adenovirus-Effective Agents
   Use EPA-registered disinfectants known to inactivate adenovirus, and respect required contact times on exam chairs, instruments, and door handles. CDCAAO

3. Dedicated Single-Patient Eye Drops and Instruments
   Prevent cross-contamination in clinics by assigning drops and tools to each patient. CDC

4. Avoid Sharing Towels, Pillowcases, or Eye Cosmetics
   Personal items can carry virus; each person should have separate items, and any used by infected individuals should be laundered separately. college-optometrists.org

5. Isolate Infected Individuals During Infectious Period
   Keep people with EKC away from work, school, or healthcare settings until symptoms significantly improve to avoid spreading to others. CDC

6. Use of Gloves and Eye Protection in Clinical Encounters
   Healthcare providers should wear disposable gloves and consider protective eyewear when examining suspected EKC cases to reduce self-contamination and spread. CDC

7. Early Recognition and Triage in Clinics
   Quickly identifying EKC allows separation of suspected cases from others, reducing in-office transmission. PMCPMC

8. Patient Counseling on Avoiding Eye Rubbing
   Training patients to avoid touching their eyes with unclean hands minimizes self-inoculation and spread. PMC

9. Routine Cleaning of Shared Clinical Spaces During Outbreaks
   Increase frequency of disinfection and consider temporary workflow changes when multiple cases are identified. CDC

10. Proper Disposal of Contaminated Materials
    Used swabs, tissues, and single-use items from infected patients should be sealed and discarded appropriately to prevent environmental contamination. PMC

---

When to See a Doctor

You should seek professional ophthalmic care if any of the following occur:

• Severe eye pain that is deep or worsening (not just mild irritation).

• Significant drop in vision or blurriness not improving with rest.

• Photophobia (light sensitivity) that prevents normal activity.

• Persistent symptoms beyond two weeks or symptoms that worsen after initial improvement.

• Suspected corneal involvement, especially if there is a hazy spot, glare, or visual distortion (suggests subepithelial infiltrates or scarring).

• Purulent discharge or signs suggesting secondary bacterial infection.

• Immunocompromised status (e.g., HIV, chemotherapy) where infections can behave atypically.

• Contact lens wearers with any signs of worsening because of higher risk of complications.

• Recurrent or bilateral severe involvement that interferes with daily life.

• Failure to respond to supportive care or confusion about diagnosis. NCBIPMCPMC

---

What to Eat and What to Avoid

What to Eat (Supportive Nutrition for Immunity and Healing)

1. Foods Rich in Vitamin A (e.g., carrots, sweet potatoes, dark leafy greens) support mucosal surface integrity, including ocular surfaces.

2. Citrus Fruits and Berries (Vitamin C) help immune cell function and antioxidant defense.

3. Fatty Fish (salmon, mackerel) provide omega-3s to reduce inflammation.

4. Lean Proteins (chicken, legumes) supply amino acids needed for tissue repair.

5. Zinc-Rich Foods (pumpkin seeds, meat, nuts) support antiviral immunity.

6. Probiotic Foods (yogurt, kefir) help gut-immune communication.

7. Hydrating Foods and Water maintain tear film and mucosal hydration.

8. Garlic and Ginger have mild immune-supportive and anti-inflammatory properties.

9. Green Tea contains polyphenols that modulate immune response.

10. Colorful Vegetables (bell peppers, spinach) provide broad micronutrient support and antioxidants. MDPI

What to Avoid

1. Excessive Refined Sugar which can blunt immune responsiveness.

2. Trans Fats and Highly Processed Foods that promote background inflammation.

3. Excessive Alcohol which impairs immune function and hydration.

4. High-Dose Vitamin A Without Medical Indication (risk of toxicity).

5. Overconsumption of Omega-6 Heavy Oils (e.g., some processed seed oils) that may tilt balance toward inflammation if unbalanced.

6. Allergenic Foods in Sensitive Individuals if they exacerbate eye rubbing or allergic inflammation.

7. Dehydrating Beverages (excessive caffeine or sugary sodas) that reduce overall hydration.

8. Unpasteurized or Contaminated Foods that could add systemic burden in vulnerable people.

9. Supplements in Excessive Doses beyond recommended (e.g., too much zinc or selenium) which can paradoxically impair immunity.

10. Self-Medicating with Unverified Eye Drops or Herbal “Remedies” that may harm the eye. MDPI

---

Frequently Asked Questions (FAQs)

1. What causes EKC?
   EKC is caused by certain adenoviruses that infect the conjunctiva and cornea, spreading easily from person to person. Verywell Health

2. Is EKC contagious?
   Yes. It is highly contagious, and affected individuals can spread it through direct contact, contaminated surfaces, or sharing towels and drops. CDCCDC

3. How long is EKC contagious?
   Often throughout the symptomatic period (typically 2–6 weeks) and sometimes slightly beyond; strict hygiene is needed the whole time. PMC

4. Is there a cure for EKC?
   There is no antiviral cure approved; treatment is supportive, focused on reducing symptoms, preventing spread, and controlling inflammation when needed. PMCCochrane Library

5. Do antibiotics help?
   Not for the viral infection itself. Antibiotics are used only to prevent or treat secondary bacterial infection if suspected. NCBI

6. Can I use steroid eye drops?
   Yes, but only under professional supervision and typically for immune-mediated corneal infiltrates; misuse can cause side effects like increased eye pressure. PJMHS OnlinePMC

7. What is the role of povidone-iodine?
   Topical povidone-iodine can reduce viral load early in the disease and, when combined with low-dose steroid in some protocols, shorten duration and severity. PMCResearchGate

8. Can I wear contact lenses during EKC?
   No. Contacts can trap virus, irritate the eye further, and increase infection risk. They should be stopped until full resolution and cleaned or replaced. PMC

9. How do I prevent spreading it to family?
   Wash hands often, avoid sharing towels or linens, use separate eye-care items, and isolate the infected person as much as possible. CDCcollege-optometrists.org

10. Will EKC affect my vision long-term?
    Most patients recover without permanent loss, but persistent subepithelial infiltrates or scarring can cause temporary or, rarely, lasting vision blurring if not managed properly. tjceo.com

11. Can supplements help?
    Supplements like vitamin C, D, zinc, and omega-3s support overall immune health but do not directly treat the virus. MDPI

12. Is there a vaccine for EKC?
    No approved vaccine exists for adenoviral EKC at this time. PMC

13. When can I return to work or school?
    After significant symptom improvement, especially when discharge lessens and the risk of passing virus to others is lower—ideally after consultation, often 1–2 weeks, depending on local outbreak control. CDC

14. Can EKC come back?
    Reinfection is possible because immunity is type-specific and wanes; good hygiene helps reduce risk. PMC

15. Are there long-term treatments if inflammation persists?
    Yes. Chronic inflammation or infiltrates can be managed with immunomodulators like topical tacrolimus, cyclosporine, or carefully tapered steroids, and in select non-healing cases advanced regenerative procedures. PMCPJMHS Online

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 03, 2025.